Justice Department secures court order blocking Trump deposition in Strzok and Page lawsuits
Justice Department secures court order blocking Trump deposition in Strzok and Page lawsuits
Airlines are offering more U.S.-Europe service than ever — but don’t expect bargains
Airlines are flying the highest number of seats between the U.S. and Europe in more than four years.
DeSantis allies could shift $86 million to help him run for president as watchdogs cry foul
Ron DeSantis, widely considered former President Donald Trump’s top potential GOP primary rival, is expected to launch his White House bid in the coming weeks.
Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
The authors said the estimated costs of Leqembi to Medicare are conservative and spending on the Alzheimer’s treatment may increase more than anticipated.
These buyback champions are shrinking their share count and analysts love them
With earnings season winding down, the buyback window is opening for certain stocks.
How to negotiate the salary for your first job: ‘Employers are expecting you to,’ says expert
A lot of new grads might not think they have leverage to negotiate their first salary but they actually do! Here are tips for how to ask for more—and get it.
As the Supreme Court weighs Biden’s student loan forgiveness, education debt swells
This year’s high school graduates could take on as much as $37,000 in student loan debt in pursuit of a bachelor’s degree, a new report shows.
Here’s why Covid vaccines will still be free for uninsured Americans as public health emergency ends
The Biden administration and drugmakers Pfizer and Moderna have announced programs that aim to help uninsured Americans access Covid shots for free.
U.S. aims to turn middle-American cities into new tech hubs with $500 million investment
The hope is to create more well-paying jobs across the nation and ensure the U.S. maintains dominance in key areas of tech innovation.
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
Pfizer CEO Albert Bourla argued the Biden administration’s plan will cut profits and force Big Pharma companies to pull back on developing medicines.
